BACKGROUND: Although some studies have identified impressive clinical gains for incarcerated HIV-seropositive injection drug users (IDUs) undergoing antiretroviral therapy (ART), the effect of incarceration on adherence to ART remains undetermined. METHODS: We used data from a long-term community-recruited cohort of HIV-seropositive IDUs, including comprehensive ART dispensation records, in a setting where HIV care is free. We estimated the relationship between the cumulative burden of incarceration, measured longitudinally, and the odds of < 95% adherence to ART, with use of multivariate modeling. RESULTS: From 1996 through 2008, 490 IDUs were recruited and contributed 2220 person-years of follow-up; 271 participants (55.3%) experienced an incarceration episode, with the number of incarcerations totaling 1156. In a multivariate model, incarceration had a strong dose-dependent effect on the likelihood of nonadherence to ART: 1-2 incarceration events (adjusted odds ratio [AOR], 1.49; 95% confidence interval [95% CI], 1.03-2.05), 3-5 events (AOR, 2.48; 95% CI, 1.62-3.65), and > 5 events (AOR, 3.11; 95% CI, 1.86-4.95). CONCLUSIONS: Among HIV-seropositive IDUs receiving ART, an increasing burden of incarceration was associated with poorer adherence in a dose-dependent fashion. Our findings support improved adherence support for HIV-seropositive IDUs experiencing incarceration.
BACKGROUND: Although some studies have identified impressive clinical gains for incarcerated HIV-seropositive injection drug users (IDUs) undergoing antiretroviral therapy (ART), the effect of incarceration on adherence to ART remains undetermined. METHODS: We used data from a long-term community-recruited cohort of HIV-seropositive IDUs, including comprehensive ART dispensation records, in a setting where HIV care is free. We estimated the relationship between the cumulative burden of incarceration, measured longitudinally, and the odds of < 95% adherence to ART, with use of multivariate modeling. RESULTS: From 1996 through 2008, 490 IDUs were recruited and contributed 2220 person-years of follow-up; 271 participants (55.3%) experienced an incarceration episode, with the number of incarcerations totaling 1156. In a multivariate model, incarceration had a strong dose-dependent effect on the likelihood of nonadherence to ART: 1-2 incarceration events (adjusted odds ratio [AOR], 1.49; 95% confidence interval [95% CI], 1.03-2.05), 3-5 events (AOR, 2.48; 95% CI, 1.62-3.65), and > 5 events (AOR, 3.11; 95% CI, 1.86-4.95). CONCLUSIONS: Among HIV-seropositive IDUs receiving ART, an increasing burden of incarceration was associated with poorer adherence in a dose-dependent fashion. Our findings support improved adherence support for HIV-seropositive IDUs experiencing incarceration.
Authors: Evan Wood; Thomas Kerr; Robert S Hogg; Ruth Zhang; Mark W Tyndall; Julio S G Montaner Journal: J Acquir Immune Defic Syndr Date: 2006-04-01 Impact factor: 3.731
Authors: Evan Wood; Robert S Hogg; Viviane Dias Lima; Thomas Kerr; Benita Yip; Brandon D L Marshall; Julio S G Montaner Journal: JAMA Date: 2008-08-06 Impact factor: 56.272
Authors: Jacques Baillargeon; Ingrid A Binswanger; Joseph V Penn; Brie A Williams; Owen J Murray Journal: Am J Psychiatry Date: 2008-12-01 Impact factor: 18.112
Authors: Evan Wood; Julio S G Montaner; Kathy Li; Ruth Zhang; Lucy Barney; Steffanie A Strathdee; Mark W Tyndall; Thomas Kerr Journal: Am J Public Health Date: 2008-01-30 Impact factor: 9.308
Authors: Elizabeth Marlow; Mary C White; Jacqueline P Tulsky; Milton Estes; Enrique Menendez Journal: J Urban Health Date: 2008-04-17 Impact factor: 3.671
Authors: Jacques Baillargeon; Thomas P Giordano; Josiah D Rich; Z Helen Wu; Katherine Wells; Brad H Pollock; David P Paar Journal: JAMA Date: 2009-02-25 Impact factor: 56.272
Authors: Emily A Wang; Kathleen A McGinnis; Jessica B Long; Kathleen M Akgün; E Jennifer Edelman; David Rimland; Karen H Wang; Amy C Justice; David A Fiellin Journal: Am J Addict Date: 2015-02-06
Authors: Sarah Ickowicz; Evan Wood; Huiru Dong; Paul Nguyen; Will Small; Thomas Kerr; Julio S G Montaner; M-J Milloy Journal: Drug Alcohol Depend Date: 2017-08-10 Impact factor: 4.492
Authors: Lianping Ti; M-J Milloy; Kate Shannon; Annick Simo; Robert S Hogg; Sylvia Guillemi; Julio Montaner; Thomas Kerr; Evan Wood Journal: Sex Transm Infect Date: 2014-02-12 Impact factor: 3.519